TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 31208433

Group type: EXPERIMENTAL
Intervention: Minima S short-stem
Number of subjects: 0

Group type: COMPARATOR
Intervention: Trilock Bone Preservation Stem
Number of subjects: 0
Study: 28687281

Group type: EXPERIMENTAL
Intervention: Head CT with generalised oedema
Number of subjects: 356

Group type: EXPERIMENTAL
Intervention: Peak NSE >38ng/l
Number of subjects: 356

Group type: EXPERIMENTAL
Intervention: Combination of peak NSE >38ng/l and generalised oedema on CT
Number of subjects: 356
Study: 26410604

Group type: EXPERIMENTAL
Intervention: PCI + OMT
Number of subjects: 1052

Group type: COMPARATOR
Intervention: OMT
Number of subjects: 1052
Study: 23588803

Group type: EXPERIMENTAL
Intervention: Traditional psychological interventions (pain management training, biofeedback)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Recent developments (sensory discrimination training, mirror treatment, graded motor imagery, prosthesis training, training in virtual reality)
Number of subjects: 0
Study: 21329022

Group type: EXPERIMENTAL
Intervention: Guided imagery (GI)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Music group (control)
Number of subjects: 12
Study: 19808455

Group type: EXPERIMENTAL
Intervention: Pulmonary vein antrum isolation (PVAI)
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: PVAI followed by CFAEs
Number of subjects: 103

Group type: COMPARATOR
Intervention: Complex fractionated atrial electrograms (CFAEs)
Number of subjects: 103
Study: 17342992

Group type: EXPERIMENTAL
Intervention: Compound Shenhua Tablet (SHT)
Number of subjects: 131

Group type: COMPARATOR
Intervention: Fosinopril (positive control)
Number of subjects: 131
Study: 14990014

Group type: COMPARATOR
Intervention: Propranolol 10-20 mg orally three times a day for 7 days
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Octreotide 0.05 mg subcutaneously two times a day for 3 days
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Octreotide 0.1 mg subcutaneously two times a day for 3 days
Number of subjects: 30
Study: 11772796

Group type: EXPERIMENTAL
Intervention: 20 mg of midazolam (M group)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Midazolam vehicle (P group)
Number of subjects: 50
Study: 10322686

Group type: EXPERIMENTAL
Intervention: Hepatitis B vaccination in urban DSPs
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Hepatitis B vaccination in rural DSPs
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Integration of neonates vaccination against HB program with routine EPI in urban DSPs
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Integration of neonates vaccination against HB program with routine EPI in rural DSPs
Number of subjects: 112
Study: 8574122

Group type: EXPERIMENTAL
Intervention: Air dive to a pressure of 0.49 MPa for 40 min with a decompression stop of 5 min at 0.16 MPa and 10 min at 0.13 MPa.
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control exposure breathing O2 at atmospheric pressure for 40 min.
Number of subjects: 12
Study: 2649317

Group type: EXPERIMENTAL
Intervention: buspirone (24.5 mg daily)
Number of subjects: 367

Group type: EXPERIMENTAL
Intervention: diazepam (20.8 mg daily, range 10 mg to 60 mg)
Number of subjects: 367

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 367
Study: 715070

Group type: EXPERIMENTAL
Intervention: Vaginal suppositories of 15(S)15 methyl prostaglandin F2 alpha methyl ester (50 cases)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Primary surgery (50 cases)
Number of subjects: 100
Study: 30636746

Group type: EXPERIMENTAL
Intervention: Subjective perception of grip force exertion using % Maximum Voluntary Contraction (MVC)
Number of subjects: 9
Study: 29045302

Group type: EXPERIMENTAL
Intervention: Pregnenolone (add-on treatment)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 53
Study: 26388424

Group type: EXPERIMENTAL
Intervention: Mesalazine (mesalamine)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 23870532

Group type: EXPERIMENTAL
Intervention: Real attention bias retraining
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Real alcohol/no-go training
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Real approach bias retraining
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo attention bias retraining
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo alcohol/no-go training
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo approach bias retraining
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: All real CBM conditions
Number of subjects: 0

Group type: COMPARATOR
Intervention: All placebo conditions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Percentage of participants drinking within sensible drinking limits
Number of subjects: 0
Study: 21821994

Group type: EXPERIMENTAL
Intervention: Ureteroscopic retrieval under local anesthesia
Number of subjects: 67

Group type: COMPARATOR
Intervention: Cystoscopic retrieval under local anesthesia
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Cost of flexible instruments
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Cost of rigid instruments
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Cost per use of flexible instruments
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Cost per use of rigid instruments
Number of subjects: 67
Study: 19708035

Group type: EXPERIMENTAL
Intervention: Adherence therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not available
Number of subjects: 0
Study: 17941026

Group type: EXPERIMENTAL
Intervention: Combination of liposomal amphotericin B (AmB) at 3 mg/kg daily and caspofungin at standard dose
Number of subjects: 30

Group type: COMPARATOR
Intervention: High-dose monotherapy with liposomal amphotericin B at 10 mg/kg daily
Number of subjects: 30
Study: 15030339

Group type: EXPERIMENTAL
Intervention: Terbinafine
Number of subjects: 993

Group type: EXPERIMENTAL
Intervention: Itraconazole pulse
Number of subjects: 993

Group type: EXPERIMENTAL
Intervention: Itraconazole continuous
Number of subjects: 993

Group type: EXPERIMENTAL
Intervention: Fluconazole
Number of subjects: 993

Group type: EXPERIMENTAL
Intervention: Griseofulvin
Number of subjects: 993
Study: 11564124

Group type: EXPERIMENTAL
Intervention: Levetiracetam (1,000-3,000 mg/day)
Number of subjects: 0
Study: 9636808

Group type: EXPERIMENTAL
Intervention: Sublingual-swallow immunotherapy (SLIT) with standardized grass-pollen extract
Number of subjects: 136

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 136
Study: 7868848

Group type: EXPERIMENTAL
Intervention: Oral tacrine (25 and 50 mg b.i.d.)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Rectal tacrine (12.5 and 25 mg b.i.d.)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Rectal tacrine
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Oral tacrine
Number of subjects: 8
Study: 3122548

Group type: EXPERIMENTAL
Intervention: Isosorbide dinitrate
Number of subjects: 111

Group type: COMPARATOR
Intervention: Nitroglycerin
Number of subjects: 111
Study: 29506013

Group type: EXPERIMENTAL
Intervention: Normal women
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Women with PCOS
Number of subjects: 15
Study: 28625234

Group type: EXPERIMENTAL
Intervention: Observation group (GEDVI guidance)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (CVP guidance)
Number of subjects: 40
Study: 26507186

Group type: EXPERIMENTAL
Intervention: Sufficient vitamin D levels (>30 ng/ml)
Number of subjects: 237

Group type: EXPERIMENTAL
Intervention: Insufficient vitamin D (<30 ng/ml)
Number of subjects: 237

Group type: EXPERIMENTAL
Intervention: Deficient vitamin D (<20 ng/ml)
Number of subjects: 237

Group type: EXPERIMENTAL
Intervention: Each 1 ng/ml increase in 25(OH)D
Number of subjects: 237

Group type: EXPERIMENTAL
Intervention: Maternal vitamin D status
Number of subjects: 237
Study: 22879576

Group type: EXPERIMENTAL
Intervention: FRESH START diet and exercise intervention
Number of subjects: 452
Study: 20849470

Group type: EXPERIMENTAL
Intervention: 200 mg controlled-release levodopa/carbidopa
Number of subjects: 32

Group type: COMPARATOR
Intervention: Off-state (no treatment)
Number of subjects: 32
Study: 18463553

Group type: EXPERIMENTAL
Intervention: KR33%
Number of subjects: 40

Group type: COMPARATOR
Intervention: GD100%
Number of subjects: 40

Group type: COMPARATOR
Intervention: GD33%
Number of subjects: 40

Group type: COMPARATOR
Intervention: KR100%
Number of subjects: 40
Study: 16467101

Group type: EXPERIMENTAL
Intervention: Dendritic cell-MFP therapy
Number of subjects: 10
Study: 12643965

Group type: EXPERIMENTAL
Intervention: Verbal feedback about blushing (participants told they had blushed)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Verbal feedback about blushing (participants told they had not blushed)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Verbal feedback about blushing
Number of subjects: 56
Study: 10861142

Group type: EXPERIMENTAL
Intervention: Face Mask (FM)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Laryngeal Mask Airway with fully inflated cuff (LMA-High)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Laryngeal Mask Airway with semi-inflated cuff (LMA-Low)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Laryngeal Mask Airway (LMA-Low)
Number of subjects: 300
Study: 9359722

Group type: EXPERIMENTAL
Intervention: Clarithromycin plus clofazimine plus ethambutol (three-drug arm)
Number of subjects: 95

Group type: COMPARATOR
Intervention: Clarithromycin plus clofazimine (two-drug arm)
Number of subjects: 95
Study: 7994648

Group type: EXPERIMENTAL
Intervention: Oral Vit B2 5mg three times a day during phototherapy
Number of subjects: 34

Group type: COMPARATOR
Intervention: Control group (no Vit B2)
Number of subjects: 34
Study: 2657838

Group type: EXPERIMENTAL
Intervention: Buspirone (15 mg/day, flexible to 30 mg/day, mean daily dose 20.5 mg)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Buspirone
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 820622

Group type: EXPERIMENTAL
Intervention: TRH injection
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo injection
Number of subjects: 44
Study: 31438912

Group type: EXPERIMENTAL
Intervention: Housing First with Assertive Community Treatment (HF with ACT)
Number of subjects: 201

Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 201
Study: 29049251

Group type: EXPERIMENTAL
Intervention: Esmolol 0.5mg/kg
Number of subjects: 16

Group type: COMPARATOR
Intervention: i.v. saline (control group)
Number of subjects: 16
Study: 25902771

Group type: EXPERIMENTAL
Intervention: Anodal tDCS over M1
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Cathodal tDCS over M1
Number of subjects: 24

Group type: COMPARATOR
Intervention: Sham tDCS over M1
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: All tDCS types (anodal, cathodal, sham)
Number of subjects: 24
Study: 23179046

Group type: EXPERIMENTAL
Intervention: Carers' recovery attitudes
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Caregiving experiences
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Frequency of contacts with affected relative
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Perceptions of psychotic symptoms
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Having a partner
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Lifetime history of mental disorder
Number of subjects: 82
Study: 22043463

Group type: EXPERIMENTAL
Intervention: Flapless implant placement
Number of subjects: 40

Group type: COMPARATOR
Intervention: Open flap implant placement
Number of subjects: 40
Study: 19424716

Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen breathing (HOB)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Normobaric oxygen breathing (NOB)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Control dives
Number of subjects: 19
Study: 16731470

Group type: EXPERIMENTAL
Intervention: Group A (high PAC activity)
Number of subjects: 112

Group type: COMPARATOR
Intervention: Group B (moderate PAC activity)
Number of subjects: 112

Group type: COMPARATOR
Intervention: Group C (low PAC activity)
Number of subjects: 112
Study: 15193485

Group type: EXPERIMENTAL
Intervention: estradiol valerate/dienogest
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: estradiol/norethisterone acetate
Number of subjects: 0
Study: 10674960

Group type: COMPARATOR
Intervention: Chlorhexidine (CX) mouthrinse
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cetyl pyridinium chloride (CPC) mouthrinse
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Benzalkonium chloride (0.05% BC) mouthrinse
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Benzalkonium chloride (0.1% BC) mouthrinse
Number of subjects: 0
Study: 7857222

Group type: EXPERIMENTAL
Intervention: Subcutaneous recombinant growth hormone (rGH) 0.2 iu/kg daily for 7 days
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo (saline) injection daily for 7 days
Number of subjects: 15
Study: 2034244

Group type: EXPERIMENTAL
Intervention: Induction chemotherapy (cisplatin and fluorouracil) followed by radiation therapy
Number of subjects: 332

Group type: COMPARATOR
Intervention: Surgery followed by radiation therapy
Number of subjects: 332
Study: 16435477

Group type: EXPERIMENTAL
Intervention: Surgical treatment for duodenal ulcer
Number of subjects: 91
Study: 31351909

Group type: EXPERIMENTAL
Intervention: Glass ionomer (GI) restorations
Number of subjects: 59

Group type: COMPARATOR
Intervention: Composite resin (CR) restorations
Number of subjects: 59

Group type: COMPARATOR
Intervention: Comparison of GI and CR restorations
Number of subjects: 59
Study: 30569748

Group type: EXPERIMENTAL
Intervention: 2 mg inhaled terbutaline
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: 4 mg inhaled terbutaline
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 28083705

Group type: EXPERIMENTAL
Intervention: Mandibular Advancement Device (MAD)
Number of subjects: 64

Group type: COMPARATOR
Intervention: nasal Continuous Positive Airway Pressure (nCPAP)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Intraoral placebo appliance
Number of subjects: 64
Study: 25993590

Group type: EXPERIMENTAL
Intervention: Doxorubicin (DOX)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 81
Study: 23666746

Group type: EXPERIMENTAL
Intervention: High protein breakfast (60% of energy from protein)
Number of subjects: 8

Group type: COMPARATOR
Intervention: High fat breakfast (60% of energy from fat)
Number of subjects: 8

Group type: COMPARATOR
Intervention: High carbohydrate breakfast (60% of energy from carbohydrate)
Number of subjects: 8
Study: 21148229

Group type: EXPERIMENTAL
Intervention: Lung cancer computed tomography (CT) screening
Number of subjects: 1466

Group type: EXPERIMENTAL
Intervention: Indeterminate baseline screening result
Number of subjects: 1466

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 1466

Group type: EXPERIMENTAL
Intervention: Indeterminate result at the second screening round
Number of subjects: 1466
Study: 19695904

Group type: EXPERIMENTAL
Intervention: Total percutaneous endovascular aneurysm repair with dual 6-F Perclose-AT preclosing technique
Number of subjects: 70

Group type: COMPARATOR
Intervention: Surgical femoral cutdown
Number of subjects: 70
Study: 17188099

Group type: COMPARATOR
Intervention: Computer-generated feedback about the economy of movements (Group A)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Computer-generated feedback with expert reference values (Group B)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Verbal feedback from an expert (Group C)
Number of subjects: 45
Study: 15189398

Group type: EXPERIMENTAL
Intervention: Laparoscopically assisted hysterectomy
Number of subjects: 1380

Group type: COMPARATOR
Intervention: Conventional methods of abdominal and vaginal hysterectomy
Number of subjects: 1380
Study: 11435810

Group type: EXPERIMENTAL
Intervention: Theta power over frontal regions
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Hippocampal volumes
Number of subjects: 39

Group type: COMPARATOR
Intervention: Healthy control subjects
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Patients with mild cognitive impairment
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Patients with mild dementia
Number of subjects: 39
Study: 9557848

Group type: EXPERIMENTAL
Intervention: Assisted hatching
Number of subjects: 89

Group type: COMPARATOR
Intervention: Control (unhatched embryos)
Number of subjects: 89
Study: 9443549

Group type: EXPERIMENTAL
Intervention: Caffeine (1 mg/kg)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study: 2714503

Group type: EXPERIMENTAL
Intervention: Lamicel with intravenous oxytocin
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Lamicel with vaginal prostaglandin E2
Number of subjects: 91

Group type: COMPARATOR
Intervention: Control group with intravenous oxytocin
Number of subjects: 91

Group type: COMPARATOR
Intervention: Control group with vaginal prostaglandin E2
Number of subjects: 91
Study: 1006474

Group type: EXPERIMENTAL
Intervention: meglumine ioglycamate
Number of subjects: 100
Study: 31415206

Group type: EXPERIMENTAL
Intervention: Health warning using 'causes'
Number of subjects: 1360

Group type: EXPERIMENTAL
Intervention: Health warning using 'may contribute to'
Number of subjects: 1360
Study: 27491641

Group type: EXPERIMENTAL
Intervention: Carfilzomib and dexamethasone (Kd)
Number of subjects: 929

Group type: COMPARATOR
Intervention: Bortezomib and dexamethasone (Vd)
Number of subjects: 929
Study: 26248087

Group type: EXPERIMENTAL
Intervention: Sofosbuvir and ribavirin for 16 weeks
Number of subjects: 592

Group type: EXPERIMENTAL
Intervention: Sofosbuvir and ribavirin for 24 weeks
Number of subjects: 592

Group type: EXPERIMENTAL
Intervention: Sofosbuvir, peginterferon, and ribavirin for 12 weeks
Number of subjects: 592

Group type: EXPERIMENTAL
Intervention: Overall treatment
Number of subjects: 592
Study: 23258579

Group type: EXPERIMENTAL
Intervention: Volume-oriented incentive spirometry (VIS)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Flow-oriented incentive spirometry (FIS)
Number of subjects: 20
Study: 21863638

Group type: EXPERIMENTAL
Intervention: Combination therapy de novo of adefovir dipivoxil (ADV) 10 mg per day and lamivudine (LMV) 100 mg per day
Number of subjects: 36

Group type: COMPARATOR
Intervention: Monotherapy of lamivudine (LMV) 100 mg per day
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Combination therapy de novo of adefovir dipivoxil (ADV) and lamivudine (LMV)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Monotherapy of lamivudine (LMV)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 36
Study: 19255394

Group type: EXPERIMENTAL
Intervention: 4-hour adolescent medicine workshop using standardized patients (n = 95)
Number of subjects: 186

Group type: COMPARATOR
Intervention: Alternative workshop (n = 91)
Number of subjects: 186
Study: 16897291

Group type: EXPERIMENTAL
Intervention: 0.5% bupivacaine-soaked Surgicel in gallbladder bed
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Bupivacaine infiltrated at trocar sites
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Bupivacaine infiltrated into gallbladder bed and at trocar sites
Number of subjects: 60

Group type: COMPARATOR
Intervention: Normal saline in gallbladder bed and at trocar sites
Number of subjects: 60
Study: 15054026

Group type: EXPERIMENTAL
Intervention: New treatment (attendance of a course involving theoretical and practical sessions)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard treatment (mailed information about BSE)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: New model for missing data
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: MAR assumption
Number of subjects: 0
Study: 11388817

Group type: EXPERIMENTAL
Intervention: Hormone therapy (conjugated estrogens plus medroxyprogesterone)
Number of subjects: 2763

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2763
Study: 9133887

Group type: EXPERIMENTAL
Intervention: HIV positive patients
Number of subjects: 402

Group type: COMPARATOR
Intervention: HIV negative patients
Number of subjects: 402
Study: 8306923

Group type: EXPERIMENTAL
Intervention: Bromazepam 12 mg/d
Number of subjects: 159

Group type: COMPARATOR
Intervention: Prazeapam 40 mg/d
Number of subjects: 159
Study: 3731035

Group type: EXPERIMENTAL
Intervention: Doxorubicin plus cyclophosphamide (DOX/CTX)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Doxorubicin plus vinblastine (DOX/VBL)
Number of subjects: 52
Study: 30584287

Group type: EXPERIMENTAL
Intervention: Extracorporeal magnetic innervation (ExMI) therapy, 15 minutes, three times a week for 4 weeks
Number of subjects: 52

Group type: COMPARATOR
Intervention: Control group (no therapeutic intervention)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Experimental group (ExMI therapy) vs Control group (no intervention)
Number of subjects: 52
Study: 26448141

Group type: EXPERIMENTAL
Intervention: Artefenomel 200 mg
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Artefenomel 400 mg
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Artefenomel 800 mg
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Artefenomel 1200 mg
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Artefenomel (all doses)
Number of subjects: 82
Study: 24352479

Group type: EXPERIMENTAL
Intervention: Vitamin D treatment
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study: 22344065

Group type: EXPERIMENTAL
Intervention: Stretching of the antagonist musculature
Number of subjects: 16

Group type: COMPARATOR
Intervention: Nonstretch trial
Number of subjects: 16
Study: 19279507

Group type: EXPERIMENTAL
Intervention: Strength Training (ST) group (n = 16) participated in a supervised program 3 times per week.
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control (C) group (n = 8) continued with standard of care.
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Strength Training (ST) group (n = 16)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control (C) group (n = 8)
Number of subjects: 24
Study: 17326152

Group type: EXPERIMENTAL
Intervention: IFN‐gamma1b 100 microg, 3 times a week for 48 weeks
Number of subjects: 502

Group type: EXPERIMENTAL
Intervention: IFN‐gamma1b 200 microg, 3 times a week for 48 weeks
Number of subjects: 502

Group type: COMPARATOR
Intervention: Placebo, 3 times a week for 48 weeks
Number of subjects: 502
Study: 15654136

Group type: EXPERIMENTAL
Intervention: Timed Intercourse (TI)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Intrauterine Insemination (IUI)
Number of subjects: 140
Study: 11453313

Group type: EXPERIMENTAL
Intervention: Inhaled formoterol
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24